Ten Emerging Rare Disease Scientists Score Research Grants
While the Eagles football team left Philadelphia to compete in Super Bowl LVII, Uplifting Athletes held its Young Investigator Draft. Inspired by the NFL Draft, the event awards $200,000 in research grants to 10 all-star scientists at the beginning of their careers, and was presented by CSL Behring at Lincoln Financial Field, home of the Philadelphia Eagles.
Uplifting Athletes is a nonprofit organization that connects student-athletes across the country as well as professional athlete ambassadors with their local rare disease community to raise awareness and funds.
The sixth annual Young Investigator Draft includes 10 emerging scientists, each of whom will receive a $20,000 unrestricted grant to support their vital work in rare disease research.
“The members of our 2023 Young Investigator Draft Class represent a group of early-career, diverse researchers who are tremendous assets to the rare disease community,” said Rob Long, executive director of Uplifting Athletes. The 10 scientists that were honored span the research of rare diseases at institutions across the United States.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
